AFP and neoplasm: Collectively, among the 51 patients who achieved mCCR, 9 cases (17.6%) met the "drug-off criteria,” which included cases with pathological CR, disappearance of tumor perfusion confirmed by CEUS, and normalization of serum AFP, AFP-L3 fraction, and DCP levels for 12–24 weeks (Fig. 2a).